Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march
- 126 Downloads
We aimed to explore the association of key clinical characteristics with disease severity in atopic dermatitis (AD) and its relation to components of the atopic march in a large hospital cohort. Outpatients with AD referred to the Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark, between January 2012 and December 2017, were compared based on disease severity (SCORAD); mild (< 25), moderate (25–50) and severe (> 50). A total of 470 AD patients were included: 122 small children (< 4 years of age), 103 children/adolescents (age 4–15 years) and 245 adults (> 15 years of age). A significant difference between severity groups in small children was observed for FLG mutation carrier status (16.7 vs. 30.2 vs. 60.0% mutation carriers among patients with mild, moderate and severe AD, respectively, p = 0.012) and self-rated health (3.2 vs. 2.7 vs. 2.8 with 4 being excellent health, p = 0.022). A significant difference between severity groups in adults was observed for male sex (24.4 vs. 39.8 vs. 52.9%, p = 0.003), serum total IgE (577 vs. 1269 vs. 2379 × 103 IU/L, p < 0.001), blood eosinophil count (0.28 vs. 0.39 vs. 0.61 × 109/L, p < 0.001) and asthma (42.9 vs. 38.8 vs. 72.0%, p < 0.001). Early onset of AD (< 1 year of age) and FLG mutation was associated with more severe disease and high serum total IgE levels. In conclusion, the distribution of key clinical characteristics varies significantly according to the severity of AD measured by SCORAD. Sub-typing of AD patients related to determinants of disease severity may be helpful in establishing prognosis and targeted treatment of AD.
KeywordsAtopic dermatitis Disease characteristics Determinants Severity Atopic march
There is no funding source.
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
This study was approved by the Committee of Biomedical Research Ethics of the Capital Region of Denmark. For this type of study formal consent is not required.
- 7.Kezic S, Jakasa I (2017) Filaggrin and skin barrier function. Curr Probl Dermatol 49:1–7Google Scholar
- 12.Clausen M-L, Agner T, Thomsen SF (2015) Skin barrier dysfunction and the atopic march. Curr Treat Options Allergy 218–227. https://doi.org/10.1007/s40521-015-0056-y
- 16.Hanifin J, Rajka G (1980) Diagnostic features of atopic dermatitis. Acta Derm Venereol 92:44–47Google Scholar
- 17.Asher MI, Keil U, Anderson HR, Beasley R, Crane J, Martinez F, Mitchell EA, Pearce N, Sibbald B, Stewart AW, Strachen D, Weiland SKWH (1995) International study of asthma and allergies in childhood (ISAAC) written questionnaire: validation of the asthma component among Brazilian children. Eur Respir J 8:483–491CrossRefGoogle Scholar
- 21.Rajka G, Langeland T (1989) Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh) 144:13–14Google Scholar
- 33.Akan A, Azkur D, Civelek E et al (2014) Risk factors of severe atopic dermatitis in childhood: single-center experience. Turk J Pediatr 56:121–126Google Scholar
- 47.Marenholz I, Nickel R, Rüschendorf F, Schulz F, Esparza-Gordillo J, Kerscher T, Grüber C, Lau S, Worm M, Keil T, Kurek M, Zaluga E, Wahn ULY (2006) Information A Filaggrin loss-of-function mutations predispose to phenotypes involved in the atopic march. J Allergy Clin Immunol 118(4):866–871CrossRefGoogle Scholar